Pssst. Wanna buy some chemo drugs?
A new trend in pharmaceutical sales has raised concerns over ethics and patient safety, as companies buy up critical cancer drugs in short supply and attempt to resell them at huge markups.
Rather than operate by the dark of night on street corners, these drug dealers work in broad daylight using fax, telephone and e-mail to deluge hospitals with offers.
Experts say the so-called “gray market” is not illegal and could even be poised to surge further after US President Barack Obama issued an executive order that tried to fix the problem, but may have just opened a larger loophole.
“These are a number of very small firms that have popped up out of nowhere. Most of them are relatively new,” said Thomas Smith, director of palliative medicine at Johns Hopkins Medical Institutions. “It happens in every other market, we just don’t expect it to happen in pharmaceuticals for cancer treatment.”
Fifty-six percent of the 549 hospitals surveyed by the non-profit Institute for Safe Medication Practices (ISMP) earlier this year said they received daily solicitations from gray market vendors “to purchase medications no longer available through the manufacturer or usual wholesaler.”
Fifty-two percent admitted to buying one or more drugs from gray market vendors in the past two years, as manufacturers halted production of some generic drugs because they were no longer profitable.
“I would like to know why hospitals can’t get these products, but the ‘scalpers’ can. It is unreal to have to deal with ‘scalpers’ in healthcare,” said one survey respondent whose name was withheld by ISMP.
Drug prices ranged from 650 percent to 4,000 percent over the usual cost, said the survey, which referred to all kinds of pharmaceuticals, not just cancer drugs.
Prescription drug shortages in the US nearly tripled from 2005 to last year, according to the Department of Health and Human Services.
Just why drugs are falling out of production, particularly in cancer care, has to do with the extremely low price of generic medicines and the profit incentive that drives cancer doctors to prescribe costlier medications.
Oncologists get a portion of their pay by buying drugs wholesale and billing the government’s Medicare behemoth for reimbursement, a practice that ended up paying US doctors more than they spent on the drugs by US$1.6 billion a year.
A law signed by former US president George W. Bush in 2003 tried to clamp down on inflated billing by ordering Medicare to pay doctors based on a drug’s average selling price, plus 6 percent.
Prices were also prohibited from rising more than 6 percent every six months.
That limited the market’s ability to respond to a shortage of a generic drug by increasing its price. Manufacturers were faced with limited demand and a 90 percent price drop for a generic drug. And cancer doctors were faced with a deep cut to their bottom line.
“Why use paclitaxel [and receive 6 percent of US$312] when you can use Abraxane [for 6 percent of US$5,824]?” Smith wrote.
The rise of the gray market, viewed by experts as an unintended consequence of the Bush move, has sparked new worries about the safety of the drugs being re-sold, or that errors could be made in dosing adjustments if hospitals seek alternate medications.
It remains unknown exactly how many gray market drug vendors are out there. Five are being investigated by Congressman Elijah Cummings for offering breast, ovarian, colon and lung cancer drugs at vastly inflated prices.
Only one of those five, Allied Medical — which was singled out for offering a leukemia drug at more than US$990 A vial when the usual price was US$12 — returned a request for comment, but refused to grant an on-the-record interview.
“Recent media attention on prescription drug shortages highlights the vital role that Allied Medical Supply and other companies play to ensure that hospitals and patients have the medicines they need when they need them,” it said in a statement.
Obama last month signed an executive order to require drug manufacturers to “provide adequate advance notice of manufacturing discontinuances that could lead to shortages of drugs that are life supporting or life sustaining.”
Oncologist James Speyer, medical director of the Clinical Cancer Center at New York University Langone Medical Center, applauded the move as an important first step.
However, he said: “I don’t think it is going to address every part of the problem. I believe, as do many colleagues, that the amount of money a company can charge for the drug plays a real role here.”
Europe has avoided the problem because oncologists do not have the incentive to administer more expensive drugs, and generics cost more while brand names generally cost 20 to 40 percent less than in the US.
One solution could involve the US government partnering with cancer drug manufacturers the way it does with makers of low-cost, unprofitable vaccines, to ensure companies are paid enough to supply the market, Smith said.
“Manufacturers won’t make the drugs unless they have a stable demand and a stable profit,” he said.
Republican US lawmakers on Friday criticized US President Joe Biden’s administration after sanctioned Chinese telecoms equipment giant Huawei unveiled a laptop this week powered by an Intel artificial intelligence (AI) chip. The US placed Huawei on a trade restriction list in 2019 for contravening Iran sanctions, part of a broader effort to hobble Beijing’s technological advances. Placement on the list means the company’s suppliers have to seek a special, difficult-to-obtain license before shipping to it. One such license, issued by then-US president Donald Trump’s administration, has allowed Intel to ship central processors to Huawei for use in laptops since 2020. China hardliners
A top Vietnamese property tycoon was on Thursday sentenced to death in one of the biggest corruption cases in history, with an estimated US$27 billion in damages. A panel of three hand-picked jurors and two judges rejected all defense arguments by Truong My Lan, chair of major developer Van Thinh Phat, who was found guilty of swindling cash from Saigon Commercial Bank (SCB) over a decade. “The defendant’s actions ... eroded people’s trust in the leadership of the [Communist] Party and state,” read the verdict at the trial in Ho Chi Minh City. After the five-week trial, 85 others were also sentenced on
Conjoined twins Lori and George Schappell, who pursued separate careers, interests and relationships during lives that defied medical expectations, died this month in Pennsylvania, funeral home officials said. They were 62. The twins, listed by Guinness World Records as the oldest living conjoined twins, died on April 7 at the Hospital of the University of Pennsylvania, obituaries posted by Leibensperger Funeral Homes of Hamburg said. The cause of death was not detailed. “When we were born, the doctors didn’t think we’d make 30, but we proved them wrong,” Lori said in an interview when they turned 50, the Philadelphia Inquirer reported. The
RAMPAGE: A Palestinian man was left dead after dozens of Israeli settlers searching for a missing 14-year-old boy stormed a village in the Israeli-occupied West Bank US President Joe Biden on Friday said he expected Iran to attack Israel “sooner, rather than later” and warned Tehran not to proceed. Asked by reporters about his message to Iran, Biden simply said: “Don’t,” underscoring Washington’s commitment to defend Israel. “We are devoted to the defense of Israel. We will support Israel. We will help defend Israel and Iran will not succeed,” he said. Biden said he would not divulge secure information, but said his expectation was that an attack could come “sooner, rather than later.” Israel braced on Friday for an attack by Iran or its proxies as warnings grew of